A Single-Case Experimental Design to Study the Combination of Cognitive-Behavioral Therapy and Pharmacotherapy for Smoking Cessation
Bupropion is an anti-depressant drug which is a category of aminoketones. It is a norepinephrine-dopamine inhibitor, which is considered as a nicotine antagonist and is effective in smoking cessation. The patient was a single 21-year-old girl and she was a student and had been referred to Bijan Addi...
Main Authors: | Bijan Pirnia, Maryam Akhondi, Kambiz Pirnia, Parastoo Malekanmehr, Sima Farzaneh, Kosar Deilam, Mozhdeh Bazargan, Leila Komeilizadeh, Alireza Zahiroddin |
---|---|
Format: | Article |
Language: | English |
Published: |
Aras Part Medical International Press
2019-01-01
|
Series: | Crescent Journal of Medical and Biological Sciences |
Subjects: | |
Online Access: | http://www.cjmb.org/pdf.php?id=331 |
Similar Items
-
Review: Pharmacotherapy for smoking cessation
by: Chok Limsuwat, et al.
Published: (2018-07-01) -
A comparison of the efficacy of varenicline and bupropion and an evaluation of the effect of the medications in the context of the smoking cessation programme
by: Ali Ramazan Benli, et al.
Published: (2017-02-01) -
Evaluation of pharmacologic therapies accompanied by behavioural therapy on smoking cessation success: a prospective cohort study in Turkey
by: Kamile Marakoğlu, et al.
Published: (2017-07-01) -
An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
by: Kacper Więcław, et al.
Published: (2023-08-01) -
Menthol cigarettes and smoking cessation behavior
by: Allison C. Hoffman, et al.
Published: (2011-05-01)